Login / Signup

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.

Oriol MitjàMarc Corbacho-MonnéMaria UbalsCristian TebéJudith PeñafielAurelio TobiasEster BallanaAndrea AlemanyNúria Riera-MartíCarla A PérezClara SuñerPep LaportePol AdmellaJordi MitjàMireia CluaLaia BertranMaria SarquellaSergi GavilánJordi AraJosep M ArgimonJordi CasabonaGabriel CuatrecasasPaz CañadasAleix Elizalde-TorrentRobert FabregatMagí FarréAnna ForcadaGemma Flores-MateoEsteve MuntadaNúria NadalSilvia NarejosAroa NietoNuria PratJordi PuigCarles QuiñonesJuliana Reyes-UreñaFerran Ramírez-ViaplanaLidia RuizEva Riveira-MuñozAlba SierraCésar VelascoRosa Maria Vivanco-HidalgoAlexis SentísCamila G-BeirasBonaventura ClotetMartí Vall-Mayans
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
In patients with mild COVID-19, no benefit was observed with HCQ beyond the usual care.
Keyphrases
  • coronavirus disease
  • healthcare
  • sars cov
  • palliative care
  • respiratory syndrome coronavirus
  • quality improvement
  • pain management
  • affordable care act
  • health insurance
  • replacement therapy